the aid library

Filter

7620

Prevention and control of noncommunicable diseases in Kazakhstan. The case for investment

World Health Organization WHO (2019) C_WHO

Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and ... more

Paying Primary Health Care Centers for Performance in Rwanda

Basinga, P., Gertler, P.J., Binagwaho, A., et al. The World Bank (2010) C2

Paying for performance (P4P) provides financial incentives for providers to increase the use and quality of care. P4P can affect health care by providing incentives for providers to put more effort into specific activities, and by increasing the amount of resources available to finance the delivery ... more

WFP Regional Drought Response Plan for the Horn of Africa (January – December 2023)

World Food Programme WFP (2023) CC

After five consecutive below-average rains, the humanitarian crisis in the Horn of Africa is expanding and deepening. Combined with insecurity and macroeconomic volatility, the impact of the drought on food and nutrition security has been devastating. Across Ethiopia, Kenya and Somalia, an estima ... more

Gaps in service Utilization and service provision: an analysis of DHS and SPA Malaria data from Malawi, Senegal, and Tanzania

C. Taylor, A. Linn, W. Wang, and H. Moussa (2018) C2

Barriers to the prompt and effective diagnosis and treatment of malaria exist at both the community and health facility level. Household surveys measure malaria case management at the population level with standard indicators that assess treatment-seeking behavior, access to diagnostic testing, and ... more

UNICEF DATA: MONITORING THE SITUATION OF CHILDREN AND WOMEN (Lesotho)

United Nations Children's Fund (UNICEF) (2017)

Accessed November, 2017

Update 67 – COVID-19 in children and adolescents
recommended

World Health Organization WHO (2021) C_WHO

Manual of diagnostic ultrasound. Vol. 2 – 2nd ed.

Elisabetta Buscarini, Harald Lutz and Paoletta Mirk WHO (2013)

UNICEF Data: Monitoring the Situation of Children and Women (Namibia)

United Nations Children's Fund (UNICEF) (2017)

Accessed November, 2017

GETTING TO KNOW CEREBRAL PALSY: Module 2 - Evaluating Your Child

Hambisela - Towards Excellence in Therapy for Cerebral Palsy Cerebral Palsy Association (Eastern Cape) (2008) C2

A learning resource for facilitators, parents, caregivers, and persons with cerebral palsy | Version 1 - Released March 2008

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

World Health Organization WHO (2022) C_WHO

These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. fir ... more

Public policy challenges in light of the care crisis: The impact of the pandemic on households with children and adolescents led by women

Guzmán M. National Directorate for Economy, Equality and Gender and UNICEF (2021) C_UNICEF

The crisis caused by the COVID-19 pandemic exacerbated preexisting structural economic inequalities, and had a disproportionate impact on informal workers, especially on women and young people, who lost jobs and income. The situation was even more difficult for single-parent households led by women, ... more

Syria Crisis: Addressing Regional Mental Health Needs and Gaps in the Context of the Syria Crisis

International Medical Corps (2015) CC

The report reveals weak national mental health services overburdened by the demands placed on them by the Syria crisis. Health facilities which previously provided integrated mental health services in Syria have themselves become casualties of war, with most either destroyed, damaged or not function ... more

RWANDA: UNICEF INFO BY COUNTRY

United Nations Children's Fund (UNICEF) (2018)

Accessed June 2018 | UNICEF Data: Monitoring the Situation of Children and Women

Virtual cold chain equipment industry consultation – November 2020

UN Children's Fund UNICEF; GAVI (2020) C_UNICEF

Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.

La COVID-19 chez les enfants et les adolescents : document d’information scientifique, 29 septembre 2021

Organisation Mondiale de la Santé OMS (2021) C_WHO

Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des ... more

The Condition of the Girl Child worldwide - Fifth Edition

Indefes - Terre des Hommes (2016) C1

In the last five years, i.e. how old turned the Campaign “Indifesa” (Defenceless) in 2016, that was launched by Terre des Hommes in 2012, the world has become smaller. One can actually say that the derangements following the Arab Spring in 2011 ... more

Childhood tuberculosis in Dushanbe, Tajikistan

Kadridin Pirov, Umriniso Sirojiddinova, Oktam Bobokhojaev, et al. (2016) CC

Public health Panoram, Vol.2 Issue 1 March 2016

MAMI Care Pathway Package

MAMI, Irish Aid, Eleanor Crook Foundation (2020) CC

MAMI refers to the management of small and nutritionally at risk infants under six months of age (infants u6m) and their mothers.

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Community-based rehabilitation (CBR) for people with disabilities in Nepal: an overview

Padmani Mendi & Romi Gurung Handicap International (2007) C2

This study examines over 20 years of CBR implementation in Nepal. It includes an overview of CBR interventions, provides analysis of approaches and activities in terms of impact and sustainability and makes recommendations for future developments in ... more